Beximco Pharma - eine Perle aus Bangladesch? (Seite 36)

[Crsus]

Eine ruhige Woche:

Aktueller Kurs von Beximco 166,30 Taka = 1,62 Euro

[Crsus]

Aktueller Kurs von Beximco 165,20 Taka = 1,62 Euro , Umsatz 1.149.500 Stück.

Am Freitag in London 20.000 Stück Umsatz, letzter Kurs 0,39 Euro, das Abgeld ist also auf ca. 76 % gestiegen.

[Crsus]

Aktueller Kurs von Beximco 157,40 Taka = 1,57 Euro

[Crsus]

Nach 5 Feiertagen in Folge wird heute in Bangladesch wieder gehandelt, Kurs ist unverändert.

[Crsus]

Aktueller Kurs von Beximco 159,90 Taka = 1,58 Euro

[Crsus]

Aktueller Kurs von Beximco 160,10 Taka = 1,59 Euro

Hauptversammlung wg. der Kapitalerhöhung am 15.10.2009:

Beximco Pharmaceuticals Ltd
10 September 2009



BEXIMCO PHARMACEUTICALS LTD.




10 September, 2009




N O T I C E




Beximco Pharmaceuticals Limited ("BPL" or "the Company"; AIM Symbol: BXP) today announces that further to the announcement on 3 September 2009, notice is hereby given that an Extra-Ordinary General Meeting (EGM) of the Shareholders of the Company will be held on 15 October 2009 at 11-00 AM at BEXIMCO Industrial Park, Sarabo, Kashimpur, Gazipur to transact the following businesses as special business:-




I. To approve issuance upto 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 100 each, subject to SEC's consent to the aforesaid Preference Share Issue, on the following terms and conditions:-




1. The Preference Shares shall be converted into Ordinary Shares in two stages.




a) One-half (50%), i.e., Taka 50, of each preference share will be converted into ordinary shares on 1 February 2010 at 25 % discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 31 January 2010




b) and the remaining One-half (50%), i.e., Taka 50, of each preference share will be converted into ordinary shares on 2 May 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 30 April 2010.




2. Once Preference Shares are converted into Ordinary Shares; and lock-in period thereof expires, such ordinary shares shall be listed like other ordinary shares of the Company in the stock exchanges and tradable thereat.




3. An interim dividend at 2.5% for each quarter will be paid on 1 February 2010 and 2 May 2010 against the preference shares. Record date for interim dividend on Preference Shares shall be 31 January 2010 and 29 April 2010.




4. Shareholders on Record Date on 17 September 2009 will have the prerogative to subscribe for 1,51,15,000 Preference Shares as above on a 10:1 basis, i.e., shareholders holding 10 (ten) existing Ordinary Shares will have the prerogative to subscribe for 1 (one) Preference Shares within 25 October 2009.




5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining 2,58,85,000 Preference Shares will be privately placed.




6. Preference Shares will be issued on 1 November 2009 provided SEC's consent to the aforesaid Preference Share Issue is obtained prior to that date.




7. There will be a one year lock-in on the converted Ordinary Shares from the date of issue of the Preference Shares.




8. The Preference Shares will not be listed and/or publicly placed. However, these will be transferable like any other shares.




9. The funds raised will be used for capital expenditures to finance ongoing BMRE projects and working capital of the company.




10. An Information Memoranda will be used to facilitate investment in the aforesaid Preference Share Issue.




II. To approve increase in the Authorised Share Capital of the Company to Tk 910,00,00,000 (Taka nine hundred ten crores), consisting of 50,00,00,000 Ordinary Shares of Tk 10 each amounting to Tk 500,00,00,000 (Taka five hundred crores); and 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 100 each amounting to Tk 410,00,00,000 (Taka four hundred ten crores) in view of the aforesaid Preference Share Issue; and to amend Clause-V of the Memorandum of Association and Article-4 of the Articles of Association of the Company for the said purpose.




By order of the Board,




( Md. Asad Ullah, FCS)

Executive Director and Company Secretary




Notes:



(1) The record date shall be on 17th September 2009. The shareholders whose names will appear in the Share Register of
the Company or in the Depository Register on that date will be entitled to attend at the Extra-Ordinary General
Meeting.



(2) A member entitled to attend and vote at the Extra-Ordinary General Meeting may appoint a Proxy to attend and vote in
his/her stead. The Proxy Form, duly stamped, must be deposited at the Registered Office of the Company not later
than 48 hours before the time fixed for the meeting.



(3) Admission to the meeting room will be strictly on production of the attendance slip sent with the Notice as well as
verification of signature of member(s) and/or proxy-holder(s).



(4) No gift or benefit in cash or kind shall be paid to the holders of equity securities in terms of Clause (c) of the Notification
No.SEC/SRMI/2000-953/1950 dated 24 October 2000 for attending the EGM of the Company.







For further enquiries please visit www.beximco-pharma.com or contact:







Beximco Pharma

Nazmul Hassan MP, Managing Director

Tel: [phone], ext.2080




Libertas Capital Corporate Finance

Jakob Kinde / Anthony Rowland

Tel: [phone]




Financial Dynamics

Jonathan Birt / Susan Quigley

Tel: [phone]




Notes to Editors



About Beximco Pharmaceuticals Limited




Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.




The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.

[Crsus]

Aktueller Kurs von Beximco 163,50 Taka = 1,66 Euro

Am Freitag in London 27.265 Stück Umsatz, letzter Kurs 0,47 Euro, das Abgeld ist also auf ca. 72 % gestiegen.


Beximco führt eine Kapitalerhöhung durch, bei der man die Möglichkeit hat, Aktien mit 25 % Discount zu erwerben. Für uns derzeit uninteressant, da wir in Deutschland bzw. England die Aktien ja auch mit 72 % Discount kaufen können.




BEXIMCO PHARMACEUTICALS LTD.




3 September, 2009




PRICE-SENSITIVE INFORMATION







Beximco Pharmaceuticals Limited ("BPL" or "the Company"; AIM Symbol: BXP) today announces that at a Board meeting, held on 2 September 2009, the Board reviewed the imposition of lock-in arrangements by the Bangladesh SEC ("SEC") on shares and warrants issuable to GEM Global Yield Fund Limited ("GEM"). The SEC lock-in requirement prevents Beximco from giving tradeable, unrestricted shares to GEM and was not envisaged by either party at the time of signing the original GEM Agreement (RNS 27/01/09). While the lock-in requirement prevents Beximco from currently utilising the GEM facility, there is no breach of the original GEM Agreement.




In view of this, the Board has decided to issue up to 4,100,000 Fully Convertible, six month, 5% Dividend, Preference Shares of Taka 1,000 each ("Preference Share Issue") on the following terms and conditions, subject to shareholder approval at the Company's Extra-Ordinary General Meeting ("EGM") to be held on 15 October 2009 (with Record Date on 17 September 2009) at 11 am at BEXIMCO Industrial Park, Gazipur and SEC's consent to the aforesaid Preference Share Issue:




1. The Preference Shares shall be converted into Ordinary Shares in two stages.




a) One-half (50%), i.e., Taka 500, of each preference share, will be converted into Ordinary Shares on 1 February 2010 at a 25 % discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 31 January 2010.




b) The remaining 50%, i.e., Taka 500, of each preference share, will be converted into Ordinary Shares on 2 May 2010 at a 25 % discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 30 April 2010.




2. Once Preference Shares are converted into Ordinary Shares; and the lock-in period expires, ordinary shares will be listed like other Ordinary Shares of the Company on the stock exchanges and tradable thereafter.




3. An interim cash dividend of 2.5% for each quarter will be paid on 1 February 2010 and 2 May 2010 against the preference shares. The Record Date for the interim dividend on Preference Shares is 31 January 2010 and 29 April 2010.




4. Shareholders with a Record Date on 17 September 2009 will have the option to subscribe for 1,511,500 Preference Shares as above on a 10:1 basis, i.e., shareholders holding 10 (ten) existing Ordinary Shares will have the option to subscribe for 1 (one) Preference Shares before 25 October 2009. GDR holders in London will be entitled to participate in the Preference Share Issue and will receive additional GDRs at conversion in the ratio of one GDR for each one underlying Ordinary Share.




5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining 2,588,500 Preference Shares will be privately placed.




6. Preference Shares will be issued on 1 November 2009 provided SEC consent to and EGM approval of the Preference Share Issue is obtained prior to that date.




7. There will be a one year lock-in on the converted Ordinary Shares from the date of issue of the Preference Shares.




8. The Preference Shares will not be listed and/or publicly placed. However, these will be transferable like any other shares.




9. The funds raised will be used for capital expenditures to finance ongoing Balancing, Modernisation, Replacement & Expansion ("BMRE") projects and working capital of the company.




10. An Information Memoranda will be used to facilitate investment in the Preference Share Issue. Availability of the Information Memoranda will be notified in due course.




11. In view of the Preference Share Issue, the Authorised Share Capital of the Company will be increased to Tk 910,00,00,000 (Taka nine hundred ten crores), consisting of 50,00,00,000 Ordinary Shares of Tk 10 each amounting to Tk 500,00,00,000 (Taka five hundred crores); and 4,100,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 1,000 each amounting to Tk 410,00,00,000 (Taka four hundred ten crores).




For further enquiries please visit www.beximco-pharma.com or contact:




Beximco Pharma

Nazmul Hassan MP, Managing Director

Tel: [phone], ext.2080




Libertas Capital Corporate Finance

Jakob Kinde / Anthony Rowland

Tel: [phone]




Financial Dynamics

Jonathan Birt / Susan Quigley

Tel: [phone]




Notes to Editors



About Beximco Pharmaceuticals Limited




Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.




The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.

[Crsus]

Aktueller Kurs von Beximco 160,40 Taka = 1,63 Euro

Am Freitag in London 3.500 Stück Umsatz, letzter Kurs 0,49 Euro, das Abgeld ist also auf 70 % gestiegen.

[Crsus]

Aktueller Kurs von Beximco 164,40 Taka = 1,66 Euro

Am Freitag in London 9.600 Stück Umsatz, letzter Kurs 0,56 Euro, also ca. 66 % Abgeld.

[Crsus]

Aktueller Kurs von Beximco 166,50 Taka = 1,71 Euro

Am Freitag in London 29.115 Stück Umsatz, letzter Kurs 0,60 Euro, also immer noch ca. 65 % Abgeld.